Search - tctmd.com

Displaying 1 - 20 of 151

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1174: Impact of balloon post-dilation on long-term bioprosthesis durability after transcatheter aortic valve replacement

Presenter: Antonin Trimaille

October 28, 2025

Presentation TCT 2025

TCT 875: Parametric Finite Element Modeling of Reinforced Polymeric Leaflets for Improved Durability

Presenter: SUSAN JAMES

October 27, 2025

Presentation TCT 2025

TCT 588: 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System

Presenter: Ajay J. Kirtane

October 27, 2025

Presentation TCT 2025

Ultrasound RDN Afib: Unlocking New Indications, Powering What’s Next

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

From Policy to Practice: How Reimbursement is Shaping RDN Adoption

Presenter: Matheen A. Khuddus

October 27, 2025

Presentation TCT 2025

The Science of uRDN and Why it is My Choice for my patients

Presenter: Ajay J. Kirtane

October 27, 2025

Presentation TCT 2025

Beyond the Pivotal Trial: Real-World Impact in Uncontrolled Hypertension

Presenter: Karl Fengler

October 27, 2025

Presentation TCT 2025

The Changing Face of Patient Referral: From Clinical Studies to Commercial Programs

Presenter: Naomi D.L. Fisher

October 27, 2025

Presentation TCT 2025

Can We Improve TAVR Durability Today? Imaging-based Procedural Solutions

Presenter: Joao L. Cavalcante

October 26, 2025

Presentation NY Valves 2025

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Presenter: Suzanne J. Baron

June 26, 2025

Presentation NY Valves 2025

Mitral: Durability You Can Count On

Presenter: Bassem M. Chehab

June 26, 2025

Presentation NY Valves 2025

Two-Year Durability and Cardiac Remodeling After Transcatheter Mitral Chordal Repair (Neochord Nexus)

Presenter: Edwin Ho

June 26, 2025

Presentation NY Valves 2025

Can We Solve the Durability Issue? Insights Into New Valve Designs

Presenter: Tamim M. Nazif

June 25, 2025

Presentation THT 2025

CINCH Registry: 5-Year Evidence of Efficacy and Durability

Presenter: Klaus Witte

February 12, 2025

Presentation THT 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 12, 2025

Presentation THT 2025

Recovery From Advance HF: Candidate Selection, Durability and Magnitude of Opportunity

Presenter: Stavros Drakos

February 12, 2025

Presentation THT Abstracts 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 11, 2025

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Presenter: Julien Ternacle

October 30, 2024

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Advertisement

TCT 1174: Impact of balloon post-dilation on long-term bioprosthesis durability after transcatheter aortic valve replacement

TCT 875: Parametric Finite Element Modeling of Reinforced Polymeric Leaflets for Improved Durability

TCT 588: 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System

Ultrasound RDN Afib: Unlocking New Indications, Powering What’s Next

From Policy to Practice: How Reimbursement is Shaping RDN Adoption

The Science of uRDN and Why it is My Choice for my patients

Beyond the Pivotal Trial: Real-World Impact in Uncontrolled Hypertension

The Changing Face of Patient Referral: From Clinical Studies to Commercial Programs

Can We Improve TAVR Durability Today? Imaging-based Procedural Solutions

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Mitral: Durability You Can Count On

Two-Year Durability and Cardiac Remodeling After Transcatheter Mitral Chordal Repair (Neochord Nexus)

Can We Solve the Durability Issue? Insights Into New Valve Designs

CINCH Registry: 5-Year Evidence of Efficacy and Durability

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Recovery From Advance HF: Candidate Selection, Durability and Magnitude of Opportunity

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content